The global Gene Delivery Technologies Market size was valued at USD 1.91 billion in 2022 and is expected to reach USD 3.28 billion by 2032, growing at a CAGR of 6.2% during the forecast period. The increasing incidence of chronic diseases and the rise in spending on research and development, coupled with the demand for gene therapies, are the major factors driving the market's revenue growth. Gene delivery technologies refer to the methods used to deliver genetic material into cells to treat diseases by altering or replacing defective genes. Gene therapy has the potential to revolutionize the treatment of cancer and genetic disorders by offering a long-term cure.
The market's revenue growth is driven by the increasing prevalence of chronic diseases such as cancer, genetic disorders, and viral infections. The use of gene therapies to treat cancer has shown promising results, which is expected to increase the adoption of gene delivery technologies.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/6294
In addition, increasing investments by key players in research and development projects is also expected to drive market revenue growth. For instance, the Food and Drug Administration (FDA) in the US approved the first gene therapy for the treatment of Alzheimer's disease in June 2021.
Key players in the Gene Delivery Technologies Market:
- Thermo Fisher Scientific Inc.
- Qiagen N.V.
- F. Hoffmann-La Roche AG
- Lonza Group AG
- Becton, Dickinson and Company (BD)
- Sigma-Aldrich Corporation (Merck KGaA)
- General Electric Company (GE Healthcare)
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Promega Corporation
Major players are developing innovative gene delivery systems, including viral vectors, non-viral vectors, and electroporation systems, to increase the effectiveness and safety of gene therapies in response to the rising demand for gene therapies. Furthermore, the increasing use of gene editing technologies such as CRISPR-Cas9 and TALENs is also expected to drive market revenue growth. The precise gene modifications made possible by gene editing technologies can be used to treat genetic diseases, including sickle cell anemia and hemophilia.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/6294
However, the complex regulatory framework governing gene therapies and their high cost are major factors that could restrain market revenue growth. Gene therapies are subject to complex regulatory requirements and require significant investment to develop and commercialize. In addition, the expensive nature of gene therapies and the complicated regulatory environment are other factors that could restrain market revenue growth.
Based on type, the global gene delivery technologies market is segmented into viral and non-viral. The viral segment accounted for the largest revenue share in the global gene delivery technologies market in 2022 due to the development of viral gene therapy products for rare diseases and cancer by pharmaceutical companies and research institutions. The non-viral segment is expected to register a steadily fast revenue growth rate during the forecast period due to lower immunogenicity and safety concerns of non-viral gene delivery technologies.
Based on application, the global gene delivery technologies market is segmented into vaccines, genetic disorders, cancer treatment, and others. The cancer treatment segment registered the fastest revenue growth rate in the global gene delivery technologies market in 2022 due to the rising prevalence of cancer and the demand for personalized cancer therapies. The genetic disorders segment is expected to account for a significantly large revenue share during the forecast period because gene delivery technologies are used more frequently to treat rare genetic disorders. The vaccines segment is expected to register a moderately fast revenue growth rate during the forecast period due to ongoing research efforts for gene-based vaccines.
The North America market accounted for the largest revenue share in the global gene delivery technologies market in 2022 due to rising investments by major market participants in the development of gene therapies and the increasing prevalence of genetic disorders. The Europe market is expected to register the fastest revenue growth rate in the global gene delivery technologies market during the forecast period.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/6294
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
Browse:
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
